{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:52:31Z","timestamp":1792003951768,"version":"4.4.0"},"reference-count":54,"publisher":"Impact Journals, LLC","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,6,20]]},"DOI":"10.18632\/oncotarget.3895","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T06:31:06Z","timestamp":1442298666000},"page":"15464-15481","source":"Crossref","is-referenced-by-count":53,"title":["Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells"],"prefix":"10.18632","volume":"6","author":[{"given":"Elena","family":"Ciaglia","sequence":"first","affiliation":[{"name":"Department of Medicine and Surgery, University of Salerno, Baronissi Salerno, Italy"},{"name":"Department of Pharmacy, University of Salerno, Fisciano, Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Torelli","sequence":"additional","affiliation":[{"name":"\u201dG.Rummo\u201d Medical Hospital, Department of Neurosurgery, Benevento, Italy"},{"name":"Neurosurgery Unit A.O. San Giovanni di Dio e Ruggi d' Aragona - Salerno's School of Medicine, Largo Citt\u00e0 di Ippocrate, Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Pisanti","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Salerno, Baronissi Salerno, Italy"},{"name":"Department of Pharmacy, University of Salerno, Fisciano, Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Picardi","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Salerno, Baronissi Salerno, Italy"},{"name":"Department of Pharmacy, University of Salerno, Fisciano, Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"D\u2019Alessandro","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Salerno, Fisciano, Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Laezza","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology and Experimental Oncology, IEOS CNR, Naples, Italy"},{"name":"Department of Biology and Cellular and Molecular Pathology, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Malfitano","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Salerno, Baronissi Salerno, Italy"},{"name":"Department of Pharmacy, University of Salerno, Fisciano, Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Fiore","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Salerno, Fisciano, Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Christian Pagano","family":"Zottola","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Salerno, Fisciano, Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Proto","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Salerno, Fisciano, Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Catapano","sequence":"additional","affiliation":[{"name":"\u201dG.Rummo\u201d Medical Hospital, Department of Neurosurgery, Benevento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Gazzerro","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Salerno, Fisciano, Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Bifulco","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Salerno, Baronissi Salerno, Italy"},{"name":"Department of Pharmacy, University of Salerno, Fisciano, Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,5,11]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.seminoncol.2011.09.005","article-title":"Understanding glioblastoma tumor biology: the potential to improve current diagnosis and treatments","volume":"38","author":"Kesari","year":"2011","journal-title":"Semin Oncol"},{"key":"2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tips.2013.03.003","article-title":"The endocannabinoid signaling system in cancer","volume":"34","author":"Bifulco","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nrc3247","article-title":"Towards the use of cannabinoids as antitumour agents","volume":"12","author":"Guzm\u00e1n","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"4","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nm.f.1869","article-title":"Endocannabinoid signaling as a synaptic circuit breaker in neurological disease","volume":"14","author":"Freund","year":"2008","journal-title":"Nat Med"},{"key":"5","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1096\/fj.05-3995fje","article-title":"The endocannabinoid system drives neural progenitor proliferation","volume":"19","author":"Galve-Roperh","year":"2005","journal-title":"FASEB J"},{"key":"6","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1523\/JNEUROSCI.3101-05.2006","article-title":"The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells","volume":"26","author":"Galve-Roperh","year":"2006","journal-title":"J Neurosci"},{"key":"7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejca.2008.10.010","article-title":"A high cannabinoid CB receptor immunoreactivity is associated with disease severity and outcome in prostate cancer","volume":"45","author":"Fowler","year":"2009","journal-title":"Eur J Cancer"},{"key":"8","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/ijc.23114","article-title":"Cannabinoids in pancreatic cancer: correlation with survival and pain","volume":"122","author":"Kleeff","year":"2008","journal-title":"Int J Cancer"},{"key":"9","article-title":"Cannabinoid receptor type 1 immunoreactivity and disease severity in human epithelial ovarian tumors","volume":"211","author":"Rossiello","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10","doi-asserted-by":"crossref","first-page":"e23003","DOI":"10.1371\/journal.pone.0023003","article-title":"High tumour cannabinoid CB1 receptor immunoreactivity negatively impacts disease-specific survival in stage II microsatellite stable colorectal cancer","volume":"6","author":"Fowler","year":"2011","journal-title":"PLoS One"},{"key":"11","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1471-4159.2006.03911.x","article-title":"Cannabinoid receptors in human astroglial tumors","volume":"98","author":"Mentlein","year":"2006","journal-title":"J Neurochem"},{"key":"12","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1471-4159.2011.07625.x","article-title":"Alteration of endocannabinoid system in human gliomas","volume":"120","author":"Fu","year":"2012","journal-title":"J Neurochem"},{"key":"13","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1158\/0008-5472.CAN-11-0924","article-title":"PAX3-FOXO1 induces cannabinoid receptor 1 to enhance cell invasion and metastasis","volume":"71","author":"Grosveld","year":"2011","journal-title":"Cancer Res"},{"key":"14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1471-4159.2005.03013.x","article-title":"Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non-tumour brain tissue","volume":"93","author":"Hansen","year":"2005","journal-title":"J Neurochem"},{"key":"15","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1124\/mol.106.033118","article-title":"Rimonabant: just an antiobesity drug? Current evidence on its pleiotropic effects","volume":"71","author":"Santoro","year":"2007","journal-title":"Mol Pharmacol"},{"key":"16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.phrs.2011.11.008","article-title":"The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice","volume":"65","author":"Bifulco","year":"2012","journal-title":"Pharmacol Res"},{"key":"17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bcp.2010.04.023","article-title":"Rimonabant-induced apoptosis in leukemia cell lines: activation of caspase-dependent and -independent pathways","volume":"80","author":"Belisario","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"18","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/ijc.24483","article-title":"Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon","volume":"125","author":"Bifulco","year":"2009","journal-title":"Int J Cancer"},{"key":"19","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1182\/blood-2010-09-307355","article-title":"Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis","volume":"117","author":"Bifulco","year":"2011","journal-title":"Blood"},{"key":"20","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.1016\/j.febslet.2005.11.020","article-title":"Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma","volume":"579","author":"Sander","year":"2005","journal-title":"FEBS Lett"},{"key":"21","first-page":"8996","article-title":"MICA\/NKG2D-mediated immunogene therapy of experimental gliomas","volume":"63","author":"Weller","year":"2003","journal-title":"Cancer Res"},{"key":"22","first-page":"69","article-title":"Natural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells","volume":"4","author":"Mavilio","year":"2014","journal-title":"Front Immunol"},{"key":"23","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1172\/JCI35180","article-title":"The anticancer immune response: indispensable for therapeutic success?","volume":"118","author":"Kroemer","year":"2008","journal-title":"J Clin Invest"},{"key":"24","article-title":"Transforming growth factor-beta and its implication in the malignancy of gliomas","author":"Fortin","year":"2014","journal-title":"Target Oncol"},{"key":"25","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/neuonc\/noq082","article-title":"Glioma cancer stem cells induce immunosuppressive macrophages\/microglia","volume":"12","author":"Heimberger","year":"2010","journal-title":"Neuro Oncol"},{"key":"26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1189\/jlb.71.6.907","article-title":"Immune escape of tumors: apoptosis resistance and tumor counterattack","volume":"71","author":"Krammer","year":"2002","journal-title":"J Leukoc Biol"},{"key":"27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1124\/mol.66.2.204","article-title":"Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice","volume":"66","author":"Greenberg","year":"2004","journal-title":"Mol Pharmacol"},{"key":"28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1124\/mol.105.015040","article-title":"The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes","volume":"69","author":"Bensaid","year":"2006","journal-title":"Mol Pharmacol"},{"key":"29","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nm1421","article-title":"CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis","volume":"12","author":"Lotersztajn","year":"2006","journal-title":"Nat Med"},{"key":"30","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/hep.27686","article-title":"Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms","volume":"61","author":"Kunos","year":"2015","journal-title":"Hepatology"},{"key":"31","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/MEG.0000000000000337","article-title":"Cannabinoid receptor 1 antagonism in hepatocellular carcinoma: killing two birds with one stone","volume":"27","author":"Ciaglia","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-8674(00)81959-5","article-title":"Stat3 as an oncogene","volume":"98","author":"Darnell","year":"1999","journal-title":"Cell"},{"key":"33","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1158\/0008-5472.CAN-09-4540","article-title":"Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells","volume":"71","author":"Borg","year":"2011","journal-title":"Cancer Res"},{"key":"34","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4161\/cbt.3.11.1172","article-title":"Genome-wide analysis of STAT target genes: elucidating the mechanism of STAT-mediated oncogenesis","volume":"3","author":"Frank","year":"2004","journal-title":"Cancer Biol Ther"},{"key":"35","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molmet.2013.08.001","article-title":"Astroglial CB1 cannabinoid receptors regulate leptin signaling in mouse brain astrocytes","volume":"2","author":"Reguero","year":"2013","journal-title":"Mol Metab"},{"key":"36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brainres.2013.07.006","article-title":"Activation of STAT3 is involved in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptors in rats","volume":"1529","author":"Xiong","year":"2013","journal-title":"Brain Res"},{"key":"37","first-page":"318","article-title":"Activation of the mas oncogene during transfection of monoblastic cell line DNA","volume":"2","author":"Bartram","year":"1988","journal-title":"Leukemia"},{"key":"38","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.2727693","article-title":"Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation","volume":"244","author":"Axel","year":"1989","journal-title":"Science"},{"key":"39","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood-2003-12-4357","article-title":"The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner","volume":"104","author":"Delwel","year":"2004","journal-title":"Blood"},{"key":"40","doi-asserted-by":"crossref","first-page":"29817","DOI":"10.1074\/jbc.M109.050187","article-title":"Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands","volume":"284","author":"Abood","year":"2009","journal-title":"J Biol Chem"},{"key":"41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/onc.2010.402","article-title":"The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK","volume":"30","author":"S\u00e1nchez","year":"2011","journal-title":"Oncogene"},{"key":"42","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1038\/onc.2012.278","article-title":"The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas","volume":"32","author":"S\u00e1nchez","year":"2013","journal-title":"Oncogene"},{"key":"43","article-title":"Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling","author":"Guzm\u00e1n","year":"2014","journal-title":"J Biol Chem"},{"key":"44","doi-asserted-by":"crossref","first-page":"27346","DOI":"10.1074\/jbc.M110.115634","article-title":"Interactions between intracellular domains as key determinants of the quaternary structure and function of receptor heteromers","volume":"285","author":"Woods","year":"2010","journal-title":"J Biol Chem"},{"key":"45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjp.0706757","article-title":"mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis","volume":"148","author":"Devi","year":"2006","journal-title":"Br J Pharmacol"},{"key":"46","doi-asserted-by":"crossref","first-page":"38812","DOI":"10.1074\/jbc.M602494200","article-title":"Orexin-1 receptor cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function","volume":"281","author":"Milligan","year":"2006","journal-title":"J Biol Chem"},{"key":"47","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1038\/emboj.2011.139","article-title":"AT1R-CB(1)R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II","volume":"30","author":"Devi","year":"2011","journal-title":"EMBO J"},{"key":"48","doi-asserted-by":"crossref","first-page":"44234","DOI":"10.1074\/jbc.M112.364109","article-title":"The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55","volume":"287","author":"Waldhoer","year":"2012","journal-title":"J Biol Chem"},{"key":"49","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1182\/blood-2004-04-1294","article-title":"Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity","volume":"104","author":"Vitale","year":"2004","journal-title":"Blood"},{"key":"50","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.1128\/MCB.25.17.7432-7440.2005","article-title":"Role of Stat3 in regulating p53 expression and function","volume":"25","author":"Yu","year":"2005","journal-title":"Mol Cell Biol"},{"key":"51","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.4161\/cc.10.19.17630","article-title":"Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2","volume":"10","author":"Selivanova","year":"2011","journal-title":"Cell Cycle"},{"key":"52","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1189\/jlb.0413190","article-title":"N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation","volume":"94","author":"Bifulco","year":"2013","journal-title":"J Leukoc Biol"},{"key":"53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2014.06.005","article-title":"N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice","volume":"89","author":"Bifulco","year":"2014","journal-title":"Pharmacol Res"},{"key":"54","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1158\/1078-0432.CCR-09-0103","article-title":"Low levels of phosphorylated epidermal growth factor receptor in nonmalignant and malignant prostate tissue predict favorable outcome in prostate cancer patients","volume":"16","author":"Bergh","year":"2010","journal-title":"Clin Cancer Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.3895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T03:27:21Z","timestamp":1691983641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.3895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,11]]},"references-count":54,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2015,6,20]]}},"alternative-id":["3895","26008966"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.3895","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,11]]}}}